Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic

Hirata, Naoyuki; Yamakage, Michiaki

doi:10.1007/s00540-020-02852-1

Cited by 4 publications

(5 citation statements)

References 46 publications

(63 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients without comorbidities have a higher survival rate than patients with cardiovascular issues. The study results align with previous research that cardiovascular assessment predicts the survival rate of patients suffering from COVID-19; patients with cardiovascular problems have a lower survival rate (Hirata & Yamakage, 2021;Lakhani et al, 2022). The involvement of cardiovascular issues in COVID-19 patients admitted to the ICU and the higher mortality rate further support the idea that the survival rate of COVID-19 patients with cardiovascular comorbidities is lower (Badkoubeh et al, 2020).…”

Section: Discussionsupporting

confidence: 88%

Survival analysis of diabetes mellitus and cardiovascular patients with COVID-19: a secondary data analysis

Nugroho,

Fadlilah,

Susanto

et al. 2024

Public Health of Indonesia

View full text Add to dashboard Cite

Background: Patients with diabetes mellitus (DM) and cardiovascular disorders who suffer from COVID-19 may have an increased risk of death. Objective: This study aims to analyze the time of death and influencing factors in patients with DM and cardiovascular disorders with COVID-19. Methods: We used a retrospective observational cohort study using medical records of COVID-19 patients treated at Dr Soeradji and Penembahan Senopati hospitals from March 2020 to June 2022. There were 2,959 participants: patients without comorbidities, with DM, and with cardiovascular problems. We extracted sociodemographic and clinical data on patient characteristics using medical records. Data analysis used Kaplan-Meier and Cox regression analysis to estimate survival probability and investigate predictors of death with a 5% significance level. Results: The median survival time was highest in the group without comorbidities (70.00) and lowest in the DM+others group (21.75). Years of treatment, age, presence of comorbidities, and type of hospital were related to the survival rate of COVID-19 patients (p<0.05). Diabetes mellitus and cardiovascular system disorders are significantly associated with survival of COVID-19 patients (p<0.001). There were significant differences between patients without cardiovascular disorders and patients with cardiovascular disorders (Non-Hypertension, Hypertension, and Hypertension + Others) adjusted by year, gender, age, and hospital type (p<0.001). There were significant differences between patients without DM and patients with DM (DM only, DM+Hypertension, and DM+Others) adjusted by year, gender, age, and hospital type(p<0.001). Conclusion: Years of treatment, age, gender, comorbid DM, and cardiovascular problems are associated with the survival rate of COVID-19 patients. Older age, DM patients who have comorbidities other than hypertension, and patients with cardiovascular issues other than hypertension show a greater risk of death than other groups. Key words: COVID-19, Diabetes Mellitus, Hypertension, Cardiovascular Diseases, Survival Rate.

show abstract

Section: Discussionsupporting

confidence: 88%

Survival analysis of diabetes mellitus and cardiovascular patients with COVID-19: a secondary data analysis

Nugroho,

Fadlilah,

Susanto

et al. 2024

Public Health of Indonesia

View full text Add to dashboard Cite

show abstract

“…COVID-19 has continued to spread, because it has a pre-symptomatic period of up to 2 weeks during which SARS-CoV-2 can be transmitted to other individuals [ 1 ]. Most SARS-CoV-2-infected individuals have mild or moderate symptoms; however, some individuals have a severe clinical course [ 2 ]. Because SARS-CoV-2 transmission increases with exposure to droplets and secretions, anesthesiologists have higher risks of SARS-CoV-2 transmission during procedures, including mask ventilation, tracheal intubation, extubation, tracheostomy, and bronchoscopy [ 3 , 4 ].…”

Section: Introductionmentioning

confidence: 99%

Preoperative assessment for scheduling surgery during the coronavirus disease pandemic

Suehiro

2021

J Anesth

View full text Add to dashboard Cite

On Mar 11, 2020, the World Health Organization declared coronavirus disease , caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a pandemic. Because COVID-19 has a pre-symptomatic period of up to 2 weeks, SARS-CoV-2 infection has continued to spread. Some individuals with SARS-CoV-2 infection have a severe clinical course, while most individuals have mild or moderate symptoms. Because SARS-CoV-2 is transmitted via droplets and secretions, anesthesiologists have higher risks of infection, especially during airway management. Therefore, general anesthesia requiring airway management can be a challenging procedure for anesthesiologists. During the pandemic, many elective surgeries have been postponed or cancelled in most affected countries. Recently, the number of elective surgeries is gradually recovering from the effect of the COVID-19 pandemic, and hence, safe clinical practice and protocols to prevent SARS-CoV-2 transmission to medical staff should be established. This mini-review focuses on the preoperative assessment and decision with regard to scheduling surgery in elective and emergency cases during the COVID-19 pandemic. A standardized questionnaire and algorithm regarding COVID-19 should be used to assess surgical patients preoperatively as it increases the reproducibility and accuracy of the decision whether to proceed with surgery.

show abstract

“…We are grateful to Dr. Magoon for the helpful comments on our article [1]. As he pointed out in the letter to the editor, we have not referred to pulmonary-vascular consequences in the patients with COVID-19.…”

mentioning

confidence: 97%

Reply to the letter

Hirata

Yamakage

2020

J Anesth

Self Cite

View full text Add to dashboard Cite

Cardiovascular considerations for anesthesiologists during the COVID-19 pandemic

Cited by 4 publications

References 46 publications

Survival analysis of diabetes mellitus and cardiovascular patients with COVID-19: a secondary data analysis

Survival analysis of diabetes mellitus and cardiovascular patients with COVID-19: a secondary data analysis

Preoperative assessment for scheduling surgery during the coronavirus disease pandemic

Reply to the letter

Contact Info

Product

Resources

About